Correlation Between Tempest Therapeutics and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Tempest Therapeutics and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Cyclacel Pharmaceuticals.
Diversification Opportunities for Tempest Therapeutics and Cyclacel Pharmaceuticals
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tempest and Cyclacel is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 5.92 times more return on investment than Cyclacel Pharmaceuticals. However, Tempest Therapeutics is 5.92 times more volatile than Cyclacel Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 146.00 in Tempest Therapeutics on September 4, 2024 and sell it today you would lose (51.00) from holding Tempest Therapeutics or give up 34.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Tempest Therapeutics vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Tempest Therapeutics |
| Cyclacel Pharmaceuticals |
Tempest Therapeutics and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Tempest Therapeutics and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Tempest Therapeutics vs. Candel Therapeutics | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. Unicycive Therapeutics | Tempest Therapeutics vs. Cardio Diagnostics Holdings |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |